Investigating the patterns of treatment failure in patients with advanced stage III and IV melanoma receiving adjuvant therapy

被引:0
|
作者
Alimohamed, Asrar Iqbal
Lawless, Aleigha
Michaud, William
Sharova, Tatyana
Rauwerdink, Daan
Dedeilia, Aikaterini
Tarantino, Giuseppe
Sade-Feldman, Moshe
Liu, David
Boland, Genevieve Marie
机构
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Gen Hosp, Ctr Canc, Surg Oncol, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21532
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Treatment of patients with inoperable stage III or stage IV melanoma. Societe francaise de dermatologie
    Guillot, B.
    Charles, J.
    Jeudy, G.
    Cupissol, D.
    Dupuy, A.
    Dutriaux, C.
    Gangloff, D.
    Magne, N.
    Mirabe, X.
    M'Sadek, A.
    Pracht, M.
    Sichel, C.
    Do Outeiro, G.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 413 - 422
  • [42] Factors associated with the use of adjuvant radiation therapy in stage III melanoma
    King, Amber L. O.
    Lee, Victor
    Yu, Beverly
    Mirza, Fatima N.
    Zogg, Cheryl K.
    Yang, Daniel X.
    Tran, Thuy
    Leventhal, Jonathan
    An, Yi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
    Barker, Christopher A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 11 - 12
  • [44] Real-world treatment patterns in patients with advanced (stage III-IV) ovarian cancer in the USA and Europe
    Hall, Jennifer P.
    Chang, Jane
    Moon, Rebecca
    Higson, Olivia
    Byrne, Katherine
    Doherty, Jim P.
    Cappelleri, Joseph C.
    FUTURE ONCOLOGY, 2020, 16 (15) : 1013 - 1030
  • [45] Re-evaluation of treatment understanding and quality of life of patients with stage III/IV melanoma after completion of adjuvant therapy or one year of follow-up
    Ziemer, M.
    Fritz, A.
    Friedrich, M.
    Mehnert-Theuerkauf, A.
    Reschke, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 55 - 55
  • [46] Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
    Samlowski, Wolfram
    Robert, Nicholas J.
    Chen, Liwei
    Schenkel, Brad
    Davis, Catherine
    Moshyk, Andriy
    Kotapati, Srividya
    Poretta, Tayla
    Weber, Jeffrey S.
    CANCER MEDICINE, 2023, 12 (03): : 2378 - 2388
  • [47] Prospective clinical trial of masitinib mesylate treatment for advanced stage III and IV canine malignant melanoma
    Giuliano, A.
    Dobson, J.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2020, 61 (03) : 190 - 194
  • [48] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Ridolfi, L
    Ridolfi, R
    Riccobon, A
    De Paola, F
    Petrini, M
    Stefanelli, M
    Flamini, E
    Ravaioli, A
    Verdecchia, GM
    Trevisan, G
    Amadori, D
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162
  • [49] The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
    Arak, Haci
    Erkilic, Suna
    Yaslikaya, Sendag
    Mocan, Eda Eylemer
    Aktas, Gokmen
    Ozdemir, Melek
    Semiz, Huseyin Salih
    Kilickap, Saadettin
    Ozalp, Faruk Recep
    Sever, Ozlem Nuray
    Akdag, Goncagul
    Agaoglu, Ahmet Burak
    Ozcelik, Melike
    Sari, Murat
    Arcagok, Murat
    Anik, Hicran
    Yayla, Saziye Burcak
    Sever, Nadiye
    Acar, Fatma Pinar
    Bayrakci, Ismail
    Turhal, Serdar
    Ayhan, Murat
    Kus, Tulay
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (05) : 182 - 189
  • [50] Clinical experience with adjuvant treatment of patients with Stage III melanoma of the trunk and extremities in a developing country
    Garcia, Mauricio
    Diaz, Sandra
    Gutierrez, Angelica
    Sanchez, Jesus
    Sanchez, Ricardo
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2015, 19 (01): : 10 - 17